Home

Karah Herdman Parschauer

CIK 1677455 · EVP and Chief Legal Officer · last filed 2026-08-04

Karah Herdman Parschauer is an EVP and Chief Legal Officer who has filed 77 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing shows the insider sold $47.3K of RARE on Aug 4, 2026. Across all open-market trades the lifetime net is −$10.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions. 56 SEC filings were submitted jointly with Ultragenyx Pharmaceutical Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.93M

Companies

5

Total Filings

77

Lifetime Open-Market Net

-$10.80M

Filer Profile

Reported Address
60 LEVERONI COURT
NOVATO, CA 94949
Related Filers
Ultragenyx Pharmaceutical Inc. — 56 joint filings, latest 2026-08-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RARE EVP and Chief Legal Officer 92,562 $14.30 $1.32M -$10.47M 48 2026-08-04
TNYA Director — $0.64 — $0 6 2026-05-29
EOLS Director 77,742 $7.84 $609.5K -$324.2K 10 2026-02-19
Anebulo Pharmaceuticals, Inc. (ANEB) Delisted Director — $0.36 — $0 1 2022-10-03
ARCT Director — $14.73 — $0 3 2021-06-22

Recent Filings

77 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-04 RARE Sell (S) −1,900 -$47.3K EDGAR
2026-06-15 RARE Notice (144) −3,799 -$92.5K EDGAR
2026-06-15 RARE Sell (S) −1,899 -$46.8K EDGAR
2026-05-29 TNYA Grant (A) — $0 EDGAR
2026-04-20 RARE Grant (A) +28,895 $0 EDGAR
2026-03-10 RARE Notice (144) −3,508 -$79.5K EDGAR
2026-03-10 RARE Sell (S) −9,526 -$208.3K EDGAR
2026-03-06 RARE Notice (144) −6,018 -$128.8K EDGAR
2026-03-03 RARE Mixed +3,002 -$185.5K EDGAR
2026-02-19 EOLS Grant (A) +45,559 $0 EDGAR
Showing 1–10 of 77
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.